Stimulant Effects on Disruptive Behavior — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Stimulant Effects on Disruptive Behavior — Stella

Recruiting

Back to Attention Deficit Hyperactivity Disorder trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Key details

Phase

Post-approval study

Sponsor

Matthew J O'Brien, PhD, BCBA-D

Enrollment target

~10 participants

Started

October 2018

Primary completion

March 2027

Age range

48 Months – 12 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov